OverviewChartNewsTraderScreen

UBS Call 740 LLY 21.06.2024/  CH1322964904  /

Frankfurt Zert./UBS
2024-06-07  7:31:44 PM Chg.+1.670 Bid9:56:59 PM Ask- Underlying Strike price Expiration date Option type
10.660EUR +18.58% -
Bid Size: -		 -
Ask Size: -		 ELI LILLY 740.00 - 2024-06-21 Call
GlobeNewswire 06-06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire 06-06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
TeleTrader 06-05 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 06-04 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire 06-03 BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire 06-03 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 05-30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 05-24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 05-24 Eli Lilly to reveal $5.3B production boost
GlobeNewswire 05-23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 05-23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 05-23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
TeleTrader 05-21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 05-16 HEPHAISTOS secures €10.3 M to reach the clinical stage
GlobeNewswire 05-15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 05-09 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 05-08 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO